Scholarlink

<p><i>Coix lacryma-jobi</i> L., Poaceae, is traditionally used for the treatment of gastrointestinal disorders, yet its gastroprotective and ulcer-healing properties remain poorly explored. This study, integrating network pharmacology, <i>in vivo</i> assays, and molecular docking, demonstrates that the hydroalcoholic extract of <i>C. lacryma jobi</i> exerts its effects through convergent antioxidant, anti-inflammatory, and cytoprotective pathways. In ethanol-induced acute gastric injury, extract of <i>C. lacryma jobi</i> (100&#xa0;mg/kg) prevented the depletion of reduced glutathione levels and decreased myeloperoxidase activity. Histological and histochemical analyses confirmed preservation of gastric mucosal structure. In addition, the reversal of extract of <i>C. lacryma jobi</i> protective effects by pretreatment with <i>N</i>-ethylmaleimide, indomethacin, and Nω-nitro-<span>l</span>-arginine methyl ester (<span>l</span>-NAME) indicates the involvement of sulfhydryl groups, prostaglandins, and nitric oxide pathways in its gastroprotective mechanism. In chronic acetic acid–induced ulcer, extract of <i>C. lacryma jobi</i> not only reduced the ulcerated area but also produced clear histological improvement, characterized by re‑epithelialization, reorganization of mucosal layers, and partial restoration of glandular architecture. These activities are likely related to decreased levels of reduced glutathione, lipid hydroperoxides, and diminished myeloperoxidase activity. Network pharmacology analyses indicated that the bioactive constituents of extract of <i>C. lacryma jobi</i> primarily exert their effects by modulating inflammatory signaling pathways. Mass spectrometry identified polyphenols, among which quercetin and kaempferol exhibited the highest binding affinity to myeloperoxidase and to IL-1β in docking simulations. Furthermore, no evidence of toxicity was observed <i>in vivo</i> and <i>in silico</i> assays for extract of <i>C. lacryma jobi</i> and its bioactive compounds. Collectively, these findings demonstrate that extract of <i>C. lacryma jobi</i> exerts multi-target gastroprotective and healing effects, supporting its potential as a natural antiulcer agent.</p> Graphical Abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Integrating network pharmacology and in vivo experimentation to investigate the antiulcer mechanism of Coix lacryma-jobi

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月29日

查看全文
  • Lincon B. Somensi,
  • Daniela Miorando,
  • Amanda M. Steffler,
  • Cristian A. Dalla Vecchia,
  • Cleidiane V. Ferraz,
  • Ana Laura T. Borba,
  • Khetlyn Freschi,
  • Iuri R. Giacomelli,
  • Maike V. Buzatto,
  • Juliana C. Maccagnan,
  • Adan P. N. Marcelino,
  • Elizama de Gregório,
  • Walter A. Roman Junior

摘要

Coix lacryma-jobi L., Poaceae, is traditionally used for the treatment of gastrointestinal disorders, yet its gastroprotective and ulcer-healing properties remain poorly explored. This study, integrating network pharmacology, in vivo assays, and molecular docking, demonstrates that the hydroalcoholic extract of C. lacryma jobi exerts its effects through convergent antioxidant, anti-inflammatory, and cytoprotective pathways. In ethanol-induced acute gastric injury, extract of C. lacryma jobi (100 mg/kg) prevented the depletion of reduced glutathione levels and decreased myeloperoxidase activity. Histological and histochemical analyses confirmed preservation of gastric mucosal structure. In addition, the reversal of extract of C. lacryma jobi protective effects by pretreatment with N-ethylmaleimide, indomethacin, and Nω-nitro-l-arginine methyl ester (l-NAME) indicates the involvement of sulfhydryl groups, prostaglandins, and nitric oxide pathways in its gastroprotective mechanism. In chronic acetic acid–induced ulcer, extract of C. lacryma jobi not only reduced the ulcerated area but also produced clear histological improvement, characterized by re‑epithelialization, reorganization of mucosal layers, and partial restoration of glandular architecture. These activities are likely related to decreased levels of reduced glutathione, lipid hydroperoxides, and diminished myeloperoxidase activity. Network pharmacology analyses indicated that the bioactive constituents of extract of C. lacryma jobi primarily exert their effects by modulating inflammatory signaling pathways. Mass spectrometry identified polyphenols, among which quercetin and kaempferol exhibited the highest binding affinity to myeloperoxidase and to IL-1β in docking simulations. Furthermore, no evidence of toxicity was observed in vivo and in silico assays for extract of C. lacryma jobi and its bioactive compounds. Collectively, these findings demonstrate that extract of C. lacryma jobi exerts multi-target gastroprotective and healing effects, supporting its potential as a natural antiulcer agent.

Graphical Abstract